Solving CAR-T’s viral vector problem: Cellares and iVexSol team up to streamline manufacturing 22-Sep-2022 By Jane Byrne San Francisco based Cellares is partnering with Lexington, Massachusetts headquartered iVexSol to accelerate and improve the quality of viral vector manufacturing and transduction.
How do you expand cell therapy manufacturing to reach more patients per year? 23-May-2022 By Jane Byrne The potential of cell therapy is proven, but its impact is limited by manufacturing bottlenecks.
